EGFR and cancer: Upon stimulation of ligand, EGFR undergoes homo- or heterodimerization, which leads to autophosphorylation and subsequently turns on several downstream intracellular signaling pathways (including Ras/MAPK, PI3K/Akt, and Jak/STAT) to drive cancer growth and proliferation (2).